Personalised Health Cognitive Assistance for RehAbilitation SystEm (PHRASE): A Feasibility Study
Launched by DONDERS CENTRE FOR NEUROSCIENCE · Apr 16, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
The PHRASE study is exploring a new way to help stroke patients recover cognitive skills—such as attention, memory, and problem-solving—using a special rehabilitation technology called the Rehabilitation Gaming System (RGS). This system uses fun, interactive games that involve virtual and augmented reality to make rehabilitation more engaging and effective. The goal is to see if this technology can improve cognitive function when integrated into the everyday lives of stroke patients, especially since many people struggle to access traditional rehabilitation programs after leaving the hospital.
To participate in the study, individuals must be at least 18 years old, have experienced a stroke, and have moderate to mild movement difficulties in their arm. Participants will use the RGS at home for six weeks alongside their regular rehabilitation treatment. The study is currently looking for volunteers, and those who join will be asked to share their experiences and feedback on how well the technology works for them. This research could lead to better support for stroke recovery and help many people regain important skills that can improve their daily lives.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients presenting an ischemic or intracerebral haemorrhagic stroke
- • 2. Age \> 18 years old
- • 3. Moderate to mild proximal upper limb motor impairment Medical Research Council Scale (MRC≥2).
- • 4. Lesion localisation by clinical symptoms/signs.
- • 5. Able to sit on a chair or a wheelchair to interact with the RGS system.
- • 6. Minimal experience with smartphone technology based on the clinician's opinion
- • 7. Willing to participate and agree to comply with the trial scheme and procedures
- • 8. Must sign an Informed Consent Form (ICF) indicating that they understand the purpose and the procedures of the study.
- Exclusion Criteria:
- • 1. Presence of a condition or abnormality that, in the opinion of the investigator, would compromise the safety of the patient or the quality of the data.
- • 2. Severe cognitive capabilities that prevent the execution of the experiment, either evaluated by the MoCA \< 19 or based on the clinician's opinion.
- • 3. Arteriovenous malformation or lesions not related to a stroke.
- • 4. Severe associated impairments such as proximal but not distal spasticity, communication disabilities (sensory, Wernicke aphasia, or apraxia), major pain, or other neuromuscular impairments.
- • 5. Pre-stroke history of upper limb motor disability.
- • 6. Unable to use the RGS independently according to the clinician's observations and lacking support from a caregiver to use the RGS.
- • 7. Refusal to sign the consent form.
- • 8. No experience with smartphone technology or based on the clinician's opinion.
About Donders Centre For Neuroscience
The Donders Centre for Neuroscience is a leading research institution dedicated to advancing our understanding of the brain and its functions through innovative neuroscience research. Affiliated with Radboud University in Nijmegen, the Netherlands, the Centre integrates interdisciplinary approaches, combining cognitive neuroscience, neuroimaging, and neuropsychology to explore the complexities of neural mechanisms and cognitive processes. As a clinical trial sponsor, the Donders Centre emphasizes rigorous scientific methodologies and ethical standards, fostering collaboration among researchers and clinicians to translate findings into impactful treatments for neurological and psychiatric disorders.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Limoges, , France
Barcelona, , Spain
Cluj Napoca, Cluj, Romania
Madrid, , Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported